Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-08-03 Sale |
2020-08-05 4:17 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, Chief Commercial Officer |
1,553 | $278.39 | $432,337 | 38,426 (Indirect Direct) |
View |
| 2020-08-03 Sale |
2020-08-05 4:14 pm |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
2,330 | $278.24 | $648,290 | 33,562 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2020-08-03 Exercise |
2020-08-05 4:17 pm |
N/A 2027-02-02 |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, Chief Commercial Officer |
1,553 | $0 | 38,426 (Direct) |
View |
| 2020-08-03 Exercise |
2020-08-05 4:17 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, Chief Commercial Officer |
1,553 | $86.52 | 38,426 (Direct) |
View |
| 2020-08-03 Exercise |
2020-08-05 4:14 pm |
N/A 2027-02-02 |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
2,330 | $0 | 33,562 (Direct) |
View |
| 2020-08-03 Exercise |
2020-08-05 4:14 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
2,330 | $86.52 | 33,562 (Direct) |
View |